Saturday, October 1, 2022


Biotechnology News Magazine

Agathos Biologics Expands Laboratory Space to Support Genetic Medicine and Biomanufacturing Development

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Agathos Biologics announced today that it has signed a lease with Comstock Companies to acquire additional laboratory and office space, bringing its total to 10,000 square feet of usable space. “We are excited to expand our footprint in Fargo, North Dakota, which continues to see growth in its biotechnology industry,” said James Brown, CEO of Agathos. “The space is purpose-built for laboratory research, which will allow us to immediately increase our capacity to support our pipeline of projects.”

“We are pleased to see the growth of Agathos, adding to the space leased by life science tenants, including Sanford Health and Immunoprecise, in our research center, the former PRACS building,” said Scott Kjos, Managing Partner of Comstock Companies. “We are eager to support the growing biotechnology industry in Fargo and adding facilities and infrastructure that will enable these companies to have a positive impact on human health.”

Founded by James Brown, John Ballantyne, and Michael Chambers, Agathos Biologics is pursuing opportunities in gene therapy, nucleic acid and protein delivery, and biomanufacturing. Agathos’ mission as The Good Science Company is creation of transformative technologies benefiting patients, physicians, and researchers that are developed ethically, avoiding biological materials from sources including human embryonic stem cells and aborted fetal tissue and procuring materials with proper consent.

“The founders of Agathos Biologics believe that the explosive growth of biotechnology enables us to provide ethical alternatives to existing biomaterials that will allow us all to live healthier lives without compromising our deeply held beliefs. We look forward to leading this new approach and working within the industry to realize this vision,” added Brown.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine